Journal of Yeungnam Medical Science

영남대 의대 학술지 편집위원회 (Yeungnam University College of Medicine, Yeungnam University Institute Medical Science)
권호 표지
DOI QR코드

DOI QR Code

Recent updates in transcatheter aortic valve implantation

  • Cho, Jeonghwan (Division of Cardiology, Daegu Veterans Hospital) ;
  • Kim, Ung (Division of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center)
  • 투고 : 2018.04.18
  • 심사 : 2018.05.29
  • 발행 : 2018.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Transcatheter aortic valve implantation (TAVI) has evolved from a challenging intervention to a standardized, simple, and streamlined procedure with over 350,000 procedures performed in over 70 countries. It is now a novel alternative to surgical aortic valve replacement in patients with intermediate surgical risk and its indications have been expanded to cohorts with bicuspid aortic valves, low surgical risk, and younger age and fewer comorbidities. Attention should be paid to further reducing remaining complications, such as paravalvular aortic regurgitation, conduction abnormalities, cardiac tamponade, and stroke. The aim of this review is to provide an overview on the rapidly changing field of TAVI treatment and to explore past achievements, current issues, and future perspectives of this treatment modality.

키워드

참고문헌

  1. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006-8. https://doi.org/10.1161/01.CIR.0000047200.36165.B8
  2. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017;135:e1159-95. https://doi.org/10.1161/CIR.0000000000000503
  3. Vahl TP, Kodali SK, Leon MB. Transcatheter aortic valve replacement 2016: a modern-day "Through the Looking-Glass" adventure. J Am Coll Cardiol 2016;67:1472-87.
  4. Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005;26:2714-20. https://doi.org/10.1093/eurheartj/ehi471
  5. Krasopoulos G, Falconieri F, Benedetto U, Newton J, Sayeed R, Kharbanda R, et al. European real world trans-catheter aortic valve implantation: systematic review and meta-analysis of European national registries. J Cardiothorac Surg 2016;11:159. https://doi.org/10.1186/s13019-016-0552-6
  6. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017;38:2739-91. https://doi.org/10.1093/eurheartj/ehx391
  7. Mylotte D, Lefevre T, Sondergaard L, Watanabe Y, Modine T, Dvir D, et al. Transcatheter aortic valve replacement in bicuspid aortic valve disease. J Am Coll Cardiol 2014;64:2330-9. https://doi.org/10.1016/j.jacc.2014.09.039
  8. Yoon SH, Sharma R, Chakravarty T, Kawamori H, Maeno Y, Miyasaka M, et al. Clinical outcomes and prognostic factors of transcatheter aortic valve implantation in bicuspid aortic valve patients. Ann Cardiothorac Surg 2017;6:463-72. https://doi.org/10.21037/acs.2017.09.03
  9. Dvir D, Webb JG, Bleiziffer S, Pasic M, Waksman R, Kodali S, et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA 2014;312:162-70. https://doi.org/10.1001/jama.2014.7246
  10. Webb JG, Mack MJ, White JM, Dvir D, Blanke P, Herrmann HC, et al. Transcatheter aortic valve implantation within degenerated aortic surgical bioprostheses: PARTNER 2 valve-in-valve registry. J Am Coll Cardiol 2017;69:2253-62.
  11. Deeb GM, Chetcuti SJ, Reardon MJ, Patel HJ, Grossman PM, Schreiber T, et al. 1-year results in patients undergoing transcatheter aortic valve replacement with failed surgical bioprostheses. JACC Cardiovasc Interv 2017;10:1034-44. https://doi.org/10.1016/j.jcin.2017.03.018
  12. Barbanti M, Webb JG, Gilard M, Capodanno D, Tamburino C. Transcatheter aortic valve implantation in 2017: state of the art. EuroIntervention 2017;13(AA):AA11-21. https://doi.org/10.4244/EIJ-D-17-00567
  13. Allen KB, Chhatriwalla AK, Cohen DJ, Saxon JT, Aggarwal S, Hart A, et al. Bioprosthetic valve fracture to facilitate transcatheter valve-in-valve implantation. Ann Thorac Surg 2017;104:1501-8. https://doi.org/10.1016/j.athoracsur.2017.04.007
  14. Franzone A, Piccolo R, Siontis GC, Lanz J, Stortecky S, Praz F, et al. Transcatheter aortic valve replacement for the treatment of pure native aortic valve regurgitation: a systematic review. JACC Cardiovasc Interv 2016;9:2308-17. https://doi.org/10.1016/j.jcin.2016.08.049
  15. Sawaya FJ, Deutsch MA, Seiffert M, Yoon SH, Codner P, Wickramarachchi U, et al. Safety and efficacy of transcatheter aortic valve replacement in the treatment of pure aortic regurgitation in native valves and failing surgical bioprostheses: results from an international registry study. JACC Cardiovasc Interv 2017;10:1048-56. https://doi.org/10.1016/j.jcin.2017.03.004
  16. Wei L, Liu H, Zhu L, Yang Y, Zheng J, Guo K, et al. A new transcatheter aortic valve replacement system for predominant aortic regurgitation implantation of the J-valve and early outcome. JACC Cardiovasc Interv 2015;8:1831-41. https://doi.org/10.1016/j.jcin.2015.08.021
  17. Thyregod HG, Steinbrüchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol 2015;65:2184-94. https://doi.org/10.1016/j.jacc.2015.03.014
  18. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 2016;374:1609-20. https://doi.org/10.1056/NEJMoa1514616
  19. Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Sondergaard L, Mumtaz M, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 2017;376:1321-31. https://doi.org/10.1056/NEJMoa1700456
  20. Barbanti M, Binder RK, Freeman M, Wood DA, Leipsic J, Cheung A, et al. Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement. EuroIntervention 2013;9:929-35. https://doi.org/10.4244/EIJV9I8A156
  21. Barbanti M, Buccheri S, Rodes-Cabau J, Gulino S, Genereux P, Pilato G, et al. Transcatheter aortic valve replacement with new-generation devices: a systematic review and meta-analysis. Int J Cardiol 2017;245:83-9. https://doi.org/10.1016/j.ijcard.2017.07.083
  22. Pascual I, Carro A, Avanzas P, Hernandez-Vaquero D, Diaz R, Rozado J, et al. Vascular approaches for transcatheter aortic valve implantation. J Thorac Dis 2017;9(Suppl 6): S478-87. https://doi.org/10.21037/jtd.2017.05.73
  23. Arsalan M, Walther T. Durability of prostheses for transcatheter aortic valve implantation. Nat Rev Cardiol 2016;13:360-7. https://doi.org/10.1038/nrcardio.2016.43
  24. Latib A, Naganuma T, Abdel-Wahab M, Danenberg H, Cota L, Barbanti M, et al. Treatment and clinical outcomes of transcatheter heart valve thrombosis. Circ Cardiovasc Interv 2015;8. pii: e001779. https://doi.org/10.1161/CIRCINTERVENTIONS.114.001779
  25. Chakravarty T, Sondergaard L, Friedman J, De Backer O, Berman D, Kofoed KF, et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. Lancet 2017;389:2383-92. https://doi.org/10.1016/S0140-6736(17)30757-2
  26. Toggweiler S, Leipsic J, Binder RK, Freeman M, Barbanti M, Heijmen RH, et al. Management of vascular access in transcatheter aortic valve replacement: part 2: vascular complications. JACC Cardiovasc Interv 2013;6:767-76. https://doi.org/10.1016/j.jcin.2013.05.004
  27. Auffret V, Regueiro A, Del Trigo M, Abdul-Jawad Altisent O, Campelo-Parada F, Chiche O, et al. Predictors of early cerebrovascular events in patients with aortic stenosis undergoing transcatheter aortic valve replacement. J Am Coll Cardiol 2016;68:673-84. https://doi.org/10.1016/j.jacc.2016.05.065
  28. Kahlert P, Al-Rashid F, Dottger P, Mori K, Plicht B, Wendt D, et al. Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study. Circulation 2012;126:1245-55. https://doi.org/10.1161/CIRCULATIONAHA.112.092544
  29. Giustino G, Sorrentino S, Mehran R, Faggioni M, Dangas G. Cerebral embolic protection during TAVR: a clinical event meta-analysis. J Am Coll Cardiol 2017;69:465-6.
  30. Barbanti M, Gulino S, Costa G, Tamburino C. Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation. Expert Rev Med Devices 2017;14:135-47. https://doi.org/10.1080/17434440.2017.1282819
  31. Genereux P, Head SJ, Van Mieghem NM, Kodali S, Kirtane AJ, Xu K, et al. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol 2012;59:2317-26. https://doi.org/10.1016/j.jacc.2012.02.022
  32. Athappan G, Gajulapalli RD, Sengodan P, Bhardwaj A, Ellis SG, Svensson L, et al. Influence of transcatheter aortic valve replacement strategy and valve design on stroke after transcatheter aortic valve replacement: a meta-analysis and systematic review of literature. J Am Coll Cardiol 2014;63:2101-10. https://doi.org/10.1016/j.jacc.2014.02.540
  33. Barbanti M, Sgroi C, Imme S, Aruta P, Deste W, Gulino S, et al. Usefulness of contrast injection during balloon aortic valvuloplasty before transcatheter aortic valve replacement: a pilot study. EuroIntervention 2014;10:241-7. https://doi.org/10.4244/EIJV10I2A39
  34. Regueiro A, Linke A, Latib A, Ihlemann N, Urena M, Walther T, et al. Association between transcatheter aortic valve replacement and subsequent infective endocarditis and in-hospital death. JAMA 2016;316:1083-92. https://doi.org/10.1001/jama.2016.12347
  35. Barbanti M, Webb JG, Tamburino C, Van Mieghem NM, Makkar RR, Piazza N, et al. Outcomes of redo transcatheter aortic valve replacement for the treatment of postprocedural and late occurrence of paravalvular regurgitation and transcatheter valve failure. Circ Cardiovasc Interv 2016;9. pii:e003930. https://doi.org/10.1161/CIRCINTERVENTIONS.116.003930
  36. Babaliaros V, Devireddy C, Lerakis S, Leonardi R, Iturra SA, Mavromatis K, et al. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis. JACC Cardiovasc Interv 2014;7:898-904. https://doi.org/10.1016/j.jcin.2014.04.005
  37. Barbanti M, Capranzano P, Ohno Y, Attizzani GF, Gulino S, Imme S, et al. Early discharge after transfemoral transcatheter aortic valve implantation. Heart 2015;101:1485-90. https://doi.org/10.1136/heartjnl-2014-307351
  38. Barbanti M, Todaro D, Costa G, Pilato G, Picci A, Gulino S, et al. Optimized screening of coronary artery disease with invasive coronary angiography and ad hoc percutaneous coronary intervention during transcatheter aortic valve replacement. Circ Cardiovasc Interv 2017;10. pii: e005234. https://doi.org/10.1161/CIRCINTERVENTIONS.117.005234